臨床口腔癌化特論(一)
Clinical Oral Oncology (1)
學期
108-1
學分
2
學分
當期課號
B228
永久課號
A6578
開課單位
牙醫學系
授課教師
黎萬君、楊政杰、涂曦丰
校區
陽明
類別
選修
上課時間表
| 節 | 週五 |
|---|---|
8 16:30–17:20 | 臨床口腔癌化特論(一) YD302 2 節連堂 |
9 17:30–18:20 |
* 根據陽明交大上課時間表所列
週次計畫
| 週次 | 主題 |
|---|---|
| 第 1 週 | p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer |
| 第 2 週 | Aging-like Spontaneous Epigenetic Silencing V600E Facilitates Wnt Activation, Stemness, and Braf Induced Tumorigenesis |
| 第 3 週 | Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism |
| 第 4 週 | NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma |
| 第 5 週 | KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer |
| 第 6 週 | Perturbation of mitochondrial bioenergetics by polycations counteracts resistance to BRAFE600 inhibition in melanoma cells |
| 第 7 週 | Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy |
| 第 8 週 | Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy |
| 第 9 週 | Introduction to Immune therapy |
| 第 10 週 | Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer |
| 第 11 週 | Tumor-intrinsic PIK3CA represses tumor immunogenicity in a model of pancreatic cancer |
| 第 12 週 | CRISPER in Oral Cancer Research |
| 第 13 週 | Cancer Database |
| 第 14 週 | Oral presentation-1 |
| 第 15 週 | Oral presentation-2 |
| 第 16 週 | Oral presentation-3 |
| 第 17 週 | Oral presentation-4 |
| 第 18 週 | Final report |